- Home
- CLPR vs VANI Comparison
CLPR vs VANI Comparison
Compare CLPR & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- VANI
- Stock Information
- Founded
- CLPR 2015
- VANI 1998
- Country
- CLPR United States
- VANI United States
- Employees
- CLPR N/A
- VANI N/A
- Industry
- CLPR Real Estate Investment Trusts
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CLPR Real Estate
- VANI Health Care
- Exchange
- CLPR Nasdaq
- VANI Nasdaq
- Market Cap
- CLPR 57.8M
- VANI 68.1M
- IPO Year
- CLPR 2017
- VANI 2014
- Fundamental
- Price
- CLPR $3.80
- VANI $1.26
- Analyst Decision
- CLPR
- VANI Strong Buy
- Analyst Count
- CLPR 0
- VANI 1
- Target Price
- CLPR N/A
- VANI $4.00
- AVG Volume (30 Days)
- CLPR 74.4K
- VANI 66.4K
- Earning Date
- CLPR 05-12-2025
- VANI 05-13-2025
- Dividend Yield
- CLPR 10.00%
- VANI N/A
- EPS Growth
- CLPR N/A
- VANI N/A
- EPS
- CLPR N/A
- VANI N/A
- Revenue
- CLPR $152,413,000.00
- VANI N/A
- Revenue This Year
- CLPR N/A
- VANI N/A
- Revenue Next Year
- CLPR N/A
- VANI N/A
- P/E Ratio
- CLPR N/A
- VANI N/A
- Revenue Growth
- CLPR 8.63
- VANI N/A
- 52 Week Low
- CLPR $3.38
- VANI $0.91
- 52 Week High
- CLPR $7.12
- VANI $2.09
- Technical
- Relative Strength Index (RSI)
- CLPR 44.02
- VANI 77.37
- Support Level
- CLPR $3.84
- VANI $1.13
- Resistance Level
- CLPR $4.00
- VANI $1.16
- Average True Range (ATR)
- CLPR 0.13
- VANI 0.05
- MACD
- CLPR -0.03
- VANI 0.02
- Stochastic Oscillator
- CLPR 0.00
- VANI 92.86
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.